rs782467008
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006189.1(OMP):c.41C>T(p.Pro14Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00000891 in 1,458,322 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006189.1 missense
Scores
Clinical Significance
Conservation
Publications
- CAPN5-related vitreoretinopathyInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae)
- autosomal dominant neovascular inflammatory vitreoretinopathyInheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OMP | NM_006189.1 | c.41C>T | p.Pro14Leu | missense_variant | Exon 1 of 1 | ENST00000529803.1 | NP_006180.1 | |
CAPN5 | NM_004055.5 | c.297+9067C>T | intron_variant | Intron 3 of 12 | ENST00000648180.1 | NP_004046.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.0000125 AC: 3AN: 240762 AF XY: 0.0000152 show subpopulations
GnomAD4 exome AF: 0.00000891 AC: 13AN: 1458322Hom.: 0 Cov.: 32 AF XY: 0.0000152 AC XY: 11AN XY: 725320 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.41C>T (p.P14L) alteration is located in exon 1 (coding exon 1) of the OMP gene. This alteration results from a C to T substitution at nucleotide position 41, causing the proline (P) at amino acid position 14 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at